Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

NATCO Pharma faced a sharp decline, with a 37.75% drop in net profit in Q3 to Rs 132.4 crore due to lower formulation exports. Despite a rise in API revenue, the overall performance suffered. The ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 15,590.62 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Natco Pharma corrected a significant 32 per cent last week. The stock declined 20 per cent on Thursday and further corrected 9 per cent on Friday, dragged by the company’s weak Q3FY25 results.

Natco Pharma Stock Falls: NATCO Pharma’s share price dropped another 10% on Friday following weak earnings for the third quarter of the current fiscal year. The stock had already fallen 20% on ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Natco Pharma Ltd shares tanked during the early trading session on Thursday, February 13, 2025, after it announced weak third quarter financial results. Natco Pharma Ltd. shares tanked during the ...

Natco Pharma share price slumped nearly 19% on Thursday, in an otherwise positive broader market, after the Hyderabad-based drug maker as investors weighed weak December quarter earnings. The smallcap ...

Natco Pharma Shares Plummet 18.5%! In a stunning turn of events, Natco Pharma shares took a nosedive on February 13, 2025, leaving investors and market watchers in shock. The pharmaceutical giant, ...

Image Source : PIXABAY The counter opened gap down with a loss of 18.96 per cent. NATCO Pharma share price: The shares of NATCO Pharma Ltd, a constituent of BSE 500, tanked 20 per cent on Thursday ...

NATCO Pharma shares tumbled 20% on Thursday after the company reported a 37.75% decline in consolidated net profit in the December quarter, driven by a drop in formulation exports. New Delhi, Feb 13 ...